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Objective/background: The risk of mortality and morbidity among tuberculosis (TB) and
human immunodeficiency virus (HIV) coinfected patients is significantly higher than that
of patients infected with TB alone. The aim of this study was to evaluate the survival of
TB-HIV patients in a TB-referral center during a 10-year follow-up.
Methods: All TB-HIV patients in our referral center were enrolled in the study from 2003 to
2014, and patients were divided into two groups: HIV-TB patients without a history of TB
treatment (new cases of TB) and HIV-TB patients with a history of TB treatment. Both
groups were treated based on World Health Organization TB-treatment guidelines, and
multivariate analysis was performed to evaluate risk factors of all-cause mortality.
Results: During the study, 22 HIV-TB patients with a history of TB treatment and 263 HIV-TB
patients with newly diagnosed TB were included. Baseline demographic and clinical char-
acteristics were similar, except that miliary TB (98% vs. 2%) and mortality (97% vs. 3%;
p = 0.06) were more likely in HIV patients with newly diagnosed TB. During TB treatment
and subsequent follow-up, two patients did not respond to treatment and 92 (32.3%)
patients died, whereas the cure rate was 60%. Pneumothorax [hazard ratio (HR): 3.17],
coinfection (herpes zoster, toxoplasmosis, cytomegalovirus infection, Pneumocystis jiroveci,
candidiasis, and other opportunistic infection; HR: 1.75), CD4 < 100 cells/mL (HR: 1.96),
thrombocytopenia (HR: 2.29), and lack of treatment with antiretroviral agents (ART; HR:
2.82) were significantly associated with all-cause mortality according to multivariate
analysis.A 12-year
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study. Int. J. Mycobacteriol. (2016), http://dx.dConclusion: Our retrospective review of coinfected TB-HIV patients hospitalized in Tehran
showed that the management and monitoring of coinfection, pneumothorax and other
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